Skip to main content
MTDMettler-Toledo International, ISell5.4·$1308.43+0.62%
SellModerate Confidence
Investment thesis

Mettler-Toledo is a high-quality precision instruments business with a perfect 4-quarter earnings beat streak and best-in-class margins of 21%, but the stock has essentially reached analyst price targets with only 0.1% upside and trades below its long-term trend line, creating an unfavorable near-term entry point.

Thesis pillars

  • Best In Class MarginsStable
  • Perfect Earnings ConsistencyStable
  • Price At Target No UpsideStable
  • +1 more pillar — see the Why tab for full reasoning

Full reasoning →

Open full analysis

Mettler-Toledo International, I (MTD) Stock Analysis

Recovery setup · Catalyst-Driven edge

SellDEATH CROSS (EXEMPT)Moderate Confidence

Healthcare · Diagnostics & Research

Sell if holding. Analyst target reached at $1308.43 — A.R:R is negative (-0.9) — price has exceeded the analyst target. Reward from here is too thin for a buy — the engine flags exit. Additional concerns: Expensive valuation.

Mettler-Toledo International manufactures precision instruments and related services globally across laboratory (56% of net sales), industrial (39%), and retail weighing (5%) segments, with sales in more than 140 countries and direct presence in approximately 40 countries. The... Read more

$1308.43-1.0% A.UpsideScore 5.4/10#14 of 32 Diagnostics & Research
QualityF-score8 / 9FCF yield2.33%
Stop $1240.39Target $1295.04(resistance)A.R:R -0.9:1
Analyst target$1311.17+0.2%12 analysts
$1295.04our TP
$1308.43price
$1311.17mean
$1194
$1550

Sell if holding. Analyst target reached at $1308.43 — A.R:R is negative (-0.9) — price has exceeded the analyst target. Reward from here is too thin for a buy — the engine flags exit. Additional concerns: Expensive valuation. Chart setup: Death cross but MACD improving, RSI 82. Score 5.4/10, moderate confidence.

Passes 8/10 gates (positive momentum, clean insider activity, positive momentum, no SEC red flags, news events none recent, earnings proximity 27d clear, semi cycle peak clear, materials cycle peak clear). Fails on favorable risk/reward ratio. Suitability: moderate.

10-K grounded · weekly refresh

About Mettler-Toledo International, I

About Mettler-Toledo International, I

Mettler-Toledo International's precision instruments and services span more than 140 countries, with net sales split roughly 42% from the Americas, 29% from Europe, and 29% from Asia during 2025. Laboratory instruments and related services accounted for 56% of net sales, industrial instruments 39%, and retail weighing 5%. The company invested $199 million in research and development in 2025—approximately 5% of net sales—and employed approximately 18,100 people globally at year-end 2025.

Mettler-Toledo earns revenue through direct and indirect sales of precision instruments across five reportable segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other Operations. More technically sophisticated products are sold through the direct sales force; less complicated products, including Ohaus-branded items targeting educational markets, move through indirect channels. Service contracts, on-demand services, and replacement parts contributed approximately 25% of net sales in 2025, rising from 23% in 2023, reflecting growth in recurring revenue from a large installed base. No single end-customer accounted for more than 1% of 2025 net sales. Chinese operations accounted for 16% of external customer sales, 29% of segment profit, and 29% of global production in 2025—a combined exposure across revenue, profitability, and manufacturing supply chain. The company holds $19.2 million of cash in Chinese subsidiaries subject to government approval for conversion and repatriation. WTI geopolitical tensions between the U.S. and China, combined with the country's real estate market pressures and domestic purchasing requirements favoring local competitors, could weigh on both demand and supply-chain costs simultaneously.

Show full overview

Mettler-Toledo's 10-K identifies a distinct manufacturing concentration alongside the China exposure: many products are developed and manufactured at single locations with limited alternate facilities, and certain components are sourced from a limited or single supplier. If a significant disruption—from labor unrest, natural disaster, or cybersecurity attack—affected a key facility in China, Europe, or the United States, the company may be unable to satisfy customer demand, and the 10-K warns that customers may switch to competitors and 'may not return' even after an interruption is resolved. This single-location production structure amplifies the geographic manufacturing concentration already embedded in the Chinese operations profile.

See also: Healthcare · Diagnostics & Research

From Mettler-Toledo International, I's most recent 10-K filing, extracted June 11, 2026.

TrendMatrix Research · upcoming catalyst calendar

Upcoming dated catalysts

Thu, Jul 30, 202627d to earnings· next earnings call

Thesis

Rewards
Strong earnings beat streak (4/4)
High-quality business
Risks
Analyst target reached - limited upside remaining
Expensive valuation
Weak growth

Key Metrics

P/E (TTM)30.8
P/E (Fwd)25.5
Mkt Cap$26.4B
EV/EBITDA23.5
Profit Mgn21.4%
ROE
Rev Growth7.2%
Beta1.25
DividendNone
Rating analysts20

Quality Signals

Piotroski F8/9MoatNarrow

Options Flow

P/C0.75neutral
IV41%normal

Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results.

Show full disclosure ▾

About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.

Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.

Conflicts and positions. The TrendMatrix editorial team frequently holds personal long-term positions in securities discussed. We disclose positions held at the time of publication on each piece. We maintain a trading-window policy: we do not initiate or close positions in the same direction as a TrendMatrix publication within 24 hours before or 72 hours after publication.

No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security. Our sole compensation is subscription revenue.

No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.

Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.

Methodology · Editorial policy & full disclaimer

Rating Breakdown

3 floor-breakers

Technicals below the gate floor. Component breakdown shows what dragged the score down.static

Bollinger
0.2
Support Resistance
0.6
52w Position
7.2

Priced at a premium — multiples above sector norms. Needs delivery on growth + margins to justify.static

Ev Ebitda
0.0
Analyst Target
3.0
Peg Ratio
3.9
Pe
4.2
Forward Pe
4.9
Ps
5.9
Forward P/E: 25.5xPEG: 2.73

Growth below the gate floor. Component breakdown shows what dragged the score down.static

Earnings Growth
3.3
Revenue Growth
4.3
GatesA.R:R -0.9=NEGATIVEDeath cross exempted (quality + momentum high enough)Momentum 6.0>=5.5Insider activity: OKNo SEC red flagsNEWS EVENTS NONE RECENTEARNINGS PROXIMITY 27d clearSEMI CYCLE PEAK CLEARMATERIALS CYCLE PEAK CLEARRecoverySuitability: Moderate
RSI
82 · Overbought
20D MA 50D MA 200D MADEATH CROSSSupport $1113.90Resistance $1321.47

Price Targets

$1240
$1295
A.Upside-1.0%
A.R:R-0.9:1

Position Sizing

ConvictionNone
Suggested %0.5%
Max %1%
RegimeSteady

Risk Alerts

! Target reached (-12.8% upside)
! Negative risk/reward — downside exceeds upside

Earnings

B
B
B
B
4/4 beats
Next Earnings2026-07-30 (27d)

Verdict History

reverse chrono — latest first
Loading history...
Verdicts are recorded on every nightly pipeline run. Rows capture transitions (verdict flips, score deltas ≥0.3, entry/TP/SL changes). Rows with a ▶ can be expanded to see the change reason. Aggregate cohort performance is tracked in the recommendation ledger.
Frequently Asked Questions
Is MTD stock a buy right now?

Sell if holding. Analyst target reached at $1308.43 — A.R:R is negative (-0.9) — price has exceeded the analyst target. Reward from here is too thin for a buy — the engine flags exit. Additional concerns: Expensive valuation. Chart setup: Death cross but MACD improving, RSI 82. Prior stop was $1240.39. Score 5.4/10, moderate confidence.

What is the MTD stock price target?

Take-profit target: $1295.04 (-1.0% upside). Prior stop was $1240.39. Stop-loss: $1240.39.

What are the risks of investing in MTD?

Analyst target reached - limited upside remaining; Expensive valuation; Weak growth.

Is MTD overvalued or undervalued?

Mettler-Toledo International, I trades at a P/E of 30.8 (forward 25.5). TrendMatrix value score: 3.7/10. Verdict: Sell.

What do analysts say about MTD?

20 analysts cover MTD with a consensus score of 3.8/5. Average price target: $1311.

What does Mettler-Toledo International, I do?Mettler-Toledo International manufactures precision instruments and related services globally across laboratory (56% of...

Mettler-Toledo International manufactures precision instruments and related services globally across laboratory (56% of net sales), industrial (39%), and retail weighing (5%) segments, with sales in more than 140 countries and direct presence in approximately 40 countries. The company sells primarily through direct channels to pharma, food, chemical, and other industrial customers, with no single end-customer exceeding 1% of 2025 net sales.

Related stocks: A (Agilent Technologies, Inc.) · SHC (Sotera Health Company) · WAT (Waters Corporation) · VCYT (Veracyte, Inc.) · MEDP (Medpace Holdings, Inc.)
Home Stocks MTD

Latest news

Latest News

MarketBeat68d ago
StockStory61d agoEarnings
Yahoo Finance62d agoEarnings
MarketBeat62d agoAnalyst
MarketBeat67d agoEarnings
MarketBeat59d agoEarnings
Marketscreener.com59d agoEarnings
MarketBeat60d ago
MarketBeat64d ago
MSN64d agoEarnings
富途牛牛65d agoEarnings
MarketBeat65d ago
MarketBeat63d ago
Yahoo Finance UK65d ago
Benzinga34d agoAnalyst
Benzinga49d agoAnalyst
Benzinga54d ago
Benzinga55d agoAnalyst
Benzinga55d agoAnalyst
Benzinga56d agoAnalyst
Loading more...